Garen G Bohlin

Director · 3 filings · Latest: May 21, 2026

COLLEGIUM PHARMACEUTICAL, INC

Karyopharm Therapeutics Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
COLL	Garen G Bohlin	Director	May 11, 2026	Sale	$37.18	8,700	$323.5K	62,259	May 13 8:05 PM
COLL	Garen G Bohlin	Director	May 11, 2026	Option Exercise	$16.49	8,700	$143.5K	70,959	May 13 8:05 PM
COLL	BOHLIN GAREN G	—	May 11, 2026	Proposed Sale	$37.18	8,700	$323.5K	—	May 11 3:38 PM